Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma
La Vine, David B T, Coleman, Teresa A, Davis, Carol H, Carbonell, Christine E, Davis, Wendy B
Published in American journal of clinical oncology (01.06.2010)
Published in American journal of clinical oncology (01.06.2010)
Get more information
Journal Article